THQ · Insider Trading
abrdn Healthcare Opportunities Fund
Every open-market purchase and sale reported by THQ officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-20 | Chris LaVictoire Mahai | Director | Buy | +568 | +$10.50K |
| 2024-07-18 | Rose DiMartino | Director | Buy | +1,000 | +$21.30K |
| 2024-04-12 | Kathleen Goetz | Director | Buy | +600 | +$11.72K |
| 2024-01-04 | Todd Reit | Director | Buy | +1,000 | +$18.44K |
| 2024-01-02 | Bill Maher | Director | Buy | +1,000 | +$18.25K |
| 2022-03-24 | Kathleen Goetz | Director | Buy | +69 | +$1.50K |
| 2022-01-27 | Kathleen Goetz | Director | Buy | +479 | +$10.41K |
| 2021-03-01 | William S Reardon | Director | Buy | +1,196 | +$24.94K |
| 2020-09-23 | Jeffrey Allen Bailey | Director | Buy | +570 | +$10.08K |
| 2020-03-17 | Daniel R Omstead | President | Buy | +7,300 | +$107.10K |
| 2018-10-25 | Daniel R Omstead | President | Buy | +6,000 | +$104.58K |
| 2018-10-17 | Daniel R Omstead | President | Buy | +5,902 | +$107.37K |
| 2018-10-11 | Daniel R Omstead | President | Buy | +5,500 | +$96.76K |
| 2018-10-10 | Daniel R Omstead | President | Buy | +5,500 | +$100.47K |
| 2018-01-29 | Thomas M Kent | Director | Buy | +1,400 | +$25.90K |
| 2014-12-04 | Lucinda H Stebbins | Director | Buy | +1,000 | +$20.07K |
| 2014-07-29 | Michael W Bonney | Director | Buy | +5,000 | +$100.00K |
| 2014-07-29 | Daniel R Omstead | President | Buy | +1,000 | +$20.00K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Chris LaVictoire Mahai | Director | 568 | $10.47K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the THQ quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.